3 results match your criteria: "Xinqiao Hospital Chongqing[Affiliation]"
Am J Cancer Res
September 2021
Department of Pharmacy, Xinqiao Hospital Chongqing 400037, China.
TNBG-5602, a new synthesized derivative of tetrazanbigen, is a potential chemotherapeutic agent against cancer. However, its underlying mechanism is complex and still unknown. In this investigation, the anticancer effects of TNBG-5602 were determined in vitro and in vivo.
View Article and Find Full Text PDFInt J Clin Exp Med
January 2016
Department of Obstetrics, Shandong Province Hospital Jinan 250014, Shandong, China.
Unlabelled: To evaluate the efficacy and safety of lactulose in the intervention treatment of postpartum women with constipation.
Methods: The study adopted the multicenter clinical survey with a big sample which enrolled 4781 valid questionnaires from postpartum women in 18 different districts. All of them were treated with lactulose oral solution.
Clin Cancer Res
May 2009
Department of Oncology, Xinqiao Hospital Chongqing, PR China.